Work

[Analysis of PIKFYVE gene expression, clinical significance, and experimental validation based on TCGA database in hepatocellular carcinoma].

Year: 2025

Type: other

Abstract: PIKFYVE, as an independent risk factor, is expected to be developed into a biomarker for clinical diagnosis, offering a reference for novel therapeutic agents in HCC.

Source: PubMed

DOI: 10.3760/cma.j.cn501113-20240402-00168

Authors: L M Wen, Y L Guo, D X Zheng, Q Hou, W Dai, X Gao, J H Yang

Institutions: Xinjiang Medical University, First Affiliated Hospital of Xinjiang Medical University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Natural Science Foundation of China

Award: G7409326470

OpenAlex ID: W4404434146

Cites:

Cited by:

Related to: 10